How could you accelerate your molecule to patients?
We all could use more time and money – when you leverage Patheon Pharma Services by Thermo Fisher Scientific, you get access to over 6,500 scientists, engineers, technicians and quality specialists across 55 sites worldwide, and over $1B in recent investments and capabilities.
In this information session, we will provide a brief introduction to our capabilities in drug substance for both small molecules and biologics, drug product and clinical distribution and the investments made in each area.
Whether you start working on early or late phase development, we draw on years of experience and deep expertise to help you achieve industry-leading performance. Small and emerging companies are the majority of our clients - your program is important to us and we tailor each project to your specific molecule and clinical stage. We will support you from preclinical development all the way to commercial scale.
We will also discuss the following groundbreaking investments:
- Small Molecule API: Expansion of commercial spray drying, development and manufacturing capacity.
- Biologics: Increased capacity and capability with added process development and cell line development automation.
- Oral Solid Dose Drug Product: Bolstered solubility enhancement technologies, continuous manufacturing and additional development and commercial capabilities.
- Sterile Drug Product: Introduction of multiple new lines to add additional capacity, including additional prefilled syringe and cartridge lines and added lyophilization capacity.
Thermo Fisher Scientific is the largest life science organization in the world, and we continue to invest in capacity, technology and expertise across our global network so we can accelerate your innovation. We can respond quickly and support our customers with unprecedented scale and depth of expertise and capabilities to meet high demand for new therapies and vaccines. By simplifying the supply chain and solving complex manufacturing challenges, we shorten your development timelines in order to get high-quality medicines to patients, faster.
What could you achieve with Thermo Fisher Scientific in your corner?
Featured Speakers
Laura Chamberlain
Business Development Executive, API
Celeste Brooks
Business Development Executive, Biologics
Ian McIntosh
Business Development Executive, Drug Product
Ania Wronski
Business Development Executive, Drug Product
